Literature DB >> 8617979

Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells.

D Goletti1, A L Kinter, E C Hardy, G Poli, A S Fauci.   

Abstract

A proportion of HIV-infected individuals experience episodes of localized or systemic bacterial infections caused by Gram-negative bacteria. Many of the clinical side effects of these infections are associated with the production of proinflammatory cytokines, which are induced primarily by LPS, a constituent of the bacterial cell wall of Gram-negative bacteria. The present study examines the mechanisms involved in LPS-mediated induction of HIV expression in U1 cells, a promonocytic cell line chronically infected with HIV. Stimulation of U1 cells by LPS alone induced minimal levels of HIV expression, which was significantly enhanced by granulocyte-macrophage colony-stimulating factor (GM-CSF). Costimulation of U1 cells with LPS plus GM-CSF resulted in the accumulation of steady-state levels of HIV RNA; however, only a weak induction of HIV long terminal repeat-driven transcription, which was not associated with the activation of the cellular transcription factor nuclear factor-kappa B, was noted. Costimulation of cells with LPS plus GM-CSF induced the production of proinflammatory cytokines, IL-8, IL-1 beta and IL-6, but not TNF-alpha. IL-1 receptor antagonist (ra) inhibited LPS enhancement of HIV expression in GM-CSF-stimulated cells, suggesting that endogenous IL-1 was involved in LPS-mediated viral production. In this regard, anti-inflammatory cytokines inhibited LPS plus GM-CSF-stimulated HIV expression, and this effect closely correlated with inhibition of IL-1 beta release and, in particular, with up-regulation of endogenous IL-1ra production. Thus, the balance between an endogenously produced viral inducer (IL-1 beta ) and an inhibitor (IL-1ra) may represent an important pathway leading to modulation of HIV expression from monocytic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617979

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Interleukin-1 receptor antagonist gene polymorphism and circulating levels of human immunodeficiency virus type 1 RNA in Brazilian women.

Authors:  S S Witkin; I M Linhares; S Gerber; M E Caetano; A C Segurado
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral Latency.

Authors:  Guido Poli
Journal:  Methods Mol Biol       Date:  2022

3.  Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.

Authors:  Massimo Alfano; Samanta A Mariani; Chiara Elia; Ruggero Pardi; Francesco Blasi; Guido Poli
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

4.  Overexpression of IL-1ra gene up-regulates interleukin-1beta converting enzyme (ICE) gene expression: possible mechanism underlying IL-1beta-resistance of cancer cells.

Authors:  M Sumitomo; M Tachibana; M Murai; M Hayakawa; H Nakamura; A Takayanagi; N Shimizu
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

5.  IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity.

Authors:  HariOm Singh; Dharmesh Samani; Vijay Nema; Manisha V Ghate; R R Gangakhedkar
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

6.  Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy.

Authors:  Alessandra Romagnoli; Elisa Petruccioli; Ivana Palucci; Serena Camassa; Elisabetta Carata; Linda Petrone; Stefania Mariano; Michela Sali; Luciana Dini; Enrico Girardi; Giovanni Delogu; Delia Goletti; Gian Maria Fimia
Journal:  Cell Death Dis       Date:  2018-05-24       Impact factor: 8.469

7.  Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.

Authors:  T W Chun; D Engel; S B Mizell; L A Ehler; A S Fauci
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.